Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothea Gadzicki

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Molecular Diagnostics : JMD|January 26, 2007
A complex rearrangement in the APC gene uncovered by multiplex ligation-dependent probe amplificationConstanze Pagenstecher, Dorothea Gadzicki, Dietlinde Stienen, et al.
Journal of Community Genetics|November 24, 2011
Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and GermanyDorothea Gadzicki, D Gareth Evans, Hilary Harris, et al.
The Journal of Pathology|February 5, 2009
Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancerMatthias Christgen, Henriette Bruchhardt, Catarina Hadamitzky, et al.
European Journal of Medical Genetics|July 14, 2010
Novel CHD7 mutations contributing to the mutation spectrum in patients with CHARGE syndromeKathrin Wessels, Bettina Bohnhorst, Ingrid Luhmer, et al.
International Journal of Cancer|April 13, 2011
Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriersMichelle G Dick, Beatrix Versmold, Christoph Engel, et al.
Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriersMonika K Graeser, Christoph Engel, Kerstin Rhiem, et al.
Journal of Medical Genetics|April 9, 2013
Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer ConsortiumChristine Fischer, Karoline Kuchenbäcker, Christoph Engel, et al.
International Journal of Cancer|October 27, 2009
Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patientsKari Hemminki, Bertram Müller-Myhsok, Peter Lichtner, et al.
American Journal of Medical Genetics. Part A|February 5, 2016
Clinical delineation of the PACS1-related syndrome--Report on 19 patientsJanneke H M Schuurs-Hoeijmakers, Megan L Landsverk, Nicola Foulds, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Molecular Diagnostics : JMD|January 26, 2007
A complex rearrangement in the APC gene uncovered by multiplex ligation-dependent probe amplificationConstanze Pagenstecher, Dorothea Gadzicki, Dietlinde Stienen, et al.
Journal of Community Genetics|November 24, 2011
Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and GermanyDorothea Gadzicki, D Gareth Evans, Hilary Harris, et al.
The Journal of Pathology|February 5, 2009
Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancerMatthias Christgen, Henriette Bruchhardt, Catarina Hadamitzky, et al.
European Journal of Medical Genetics|July 14, 2010
Novel CHD7 mutations contributing to the mutation spectrum in patients with CHARGE syndromeKathrin Wessels, Bettina Bohnhorst, Ingrid Luhmer, et al.
International Journal of Cancer|April 13, 2011
Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriersMichelle G Dick, Beatrix Versmold, Christoph Engel, et al.
Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriersMonika K Graeser, Christoph Engel, Kerstin Rhiem, et al.
Journal of Medical Genetics|April 9, 2013
Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer ConsortiumChristine Fischer, Karoline Kuchenbäcker, Christoph Engel, et al.
International Journal of Cancer|October 27, 2009
Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patientsKari Hemminki, Bertram Müller-Myhsok, Peter Lichtner, et al.
American Journal of Medical Genetics. Part A|February 5, 2016
Clinical delineation of the PACS1-related syndrome--Report on 19 patientsJanneke H M Schuurs-Hoeijmakers, Megan L Landsverk, Nicola Foulds, et al.
Pageof 4